Biogen International GmbH et al v. Par Pharmaceutical, Inc. > Summary
Court Case Number 1:17-cv-04984
Filing Date Jun 30, 2017
Termination Date Nov 8, 2017
Court New York Southern District Court
Status Dismissed - Voluntarily
JudgesJesse M. Furman
Defendant
Plaintiff Attorneys
10Biogen
Attorney Name: James H. Donoian
McCarter & English
Biogen MA Inc.
Attorney Name: James H. Donoian
McCarter & English
Biogen
Attorney Name: James B. Monroe
Finnegan, Henderson, Farabow, Garrett & Dunner
Biogen
Attorney Name: Sanya Sukduang
Finnegan, Henderson, Farabow, Garrett & Dunner
Biogen
Attorney Name: Andrew E. Renison
Finnegan, Henderson, Farabow, Garrett & Dunner
Biogen
Attorney Name: Li Feng
Finnegan, Henderson, Farabow, Garrett & Dunner
Biogen MA Inc.
Attorney Name: James B. Monroe
Finnegan, Henderson, Farabow, Garrett & Dunner
Biogen MA Inc.
Attorney Name: Sanya Sukduang
Finnegan, Henderson, Farabow, Garrett & Dunner
Biogen MA Inc.
Attorney Name: Andrew E. Renison
Finnegan, Henderson, Farabow, Garrett & Dunner
Biogen MA Inc.
Attorney Name: Li Feng
Finnegan, Henderson, Farabow, Garrett & Dunner
Defendant Attorneys
Par Pharmaceutical, Inc.
Attorney Name: David Neal Wynn
ArentFox Schiff
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08399514 | Treatment for multiple sclerosis | Mar 19, 2013 |
| 07320999 | Dimethyl fumarate for the treatment of multiple sclerosis | Jan 22, 2008 |
